speb/financial-data huggingface dataset:
Financial ratios for MTH.V — annual report dated 2026-01-31
Total revenue: 0
Operating income: -626661.4814814815
Net income: -707602.2222222221
Capital expenditures: 0
Operating cash flow: -770311.8518518518
Net tangible assets: -359291.85185185185
Owner earnings: -707602.2222222221
Buffett classification: The Gruesome
Stock price: 0.05185185185185185
Shares outstanding: 106556933
Book value: -359291.85185185185
Market cap (USD): 5525174.303703704
Debt to equity: -0.6773447357353147
Current ratio: 0.2411310346122375
Quick ratio: 0.2411310346122375
Interest coverage ratio: -153.37073966642495
Free cash flow (dilution-adjusted): -939506.6666666666
Buyback yield (%): 0
Retained earnings: -6099627.407407407
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTH.V — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -433910.37037037034
Net income: -487214.07407407404
Capital expenditures: 0
Operating cash flow: -660783.7037037037
Net tangible assets: -359291.85185185185
Owner earnings: -487214.07407407404
Buffett classification: The Gruesome
Stock price: 0.05185185185185185
Shares outstanding: 106556933
Book value: -359291.85185185185
Market cap (USD): 5525174.303703704
Debt to equity: -0.6773447357353147
Current ratio: 0.2411310346122375
Quick ratio: 0.2411310346122375
Interest coverage ratio: -5230.169642857142
Free cash flow (dilution-adjusted): -660783.7037037037
Buyback yield (%): 0
Retained earnings: -6099627.407407407
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NBX.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9806157354618016
Shares outstanding: 271227657
Market cap (USD): 265970108.34663627
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NBX.OL — annual report dated 2022-12-31
Total revenue: 123596.35627530364
Gross profit: -1708280.4655870444
Operating income: -4169534.4129554653
Net income: -3629463.3603238864
Capital expenditures: 1003327.6315789473
Operating cash flow: -5691233.906882591
Depreciation & amortization: 162473.7854251012
Net tangible assets: 1042858.7044534412
Owner earnings: -4470317.206477732
Return on net tangible assets (%): -428.65991216140935
Buffett classification: The Gruesome
Stock price: 0.14878542510121456
Shares outstanding: 271227657
Book value: 6261381.983805668
P/B ratio: 6.4450184240993735
Market cap (USD): 40354722.245951414
Debt to equity: 0.3026262747352376
Current ratio: 0.6583446663898055
Quick ratio: 0.6583446663898055
Interest coverage ratio: -365.9890900691199
COGS to revenue (%): 1482.1446821473846
Free cash flow (dilution-adjusted): -6694561.538461538
Buyback yield (%): 0
Retained earnings: -9776425.303643724
Receivables turnover: 1.6447063957481998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.43115949510239
FCF margin (%): -5416.471601759678
Rule of 40 score: -5416.471601759678
Financial ratios for NBX.OL — annual report dated 2023-12-31
Total revenue: 901783.5952848723
Gross profit: -210872.8880157171
Operating income: -2686699.6070726914
Net income: -2245931.827111984
Capital expenditures: 659925.0491159136
Operating cash flow: -2070149.5088408645
Depreciation & amortization: 375151.17878192535
Net tangible assets: -1633279.4695481337
Owner earnings: -2530705.6974459724
Buffett classification: The Gruesome
Stock price: 0.06286836935166995
Shares outstanding: 271227657
Book value: 3830930.1571709225
P/B ratio: 4.451044477212918
Market cap (USD): 17051640.51866405
Debt to equity: 1.133339225811908
Current ratio: 0.35035021260749194
Quick ratio: 0.35035021260749194
Interest coverage ratio: -13.96539008279992
COGS to revenue (%): 123.38397916288359
Free cash flow (dilution-adjusted): -2730074.557956778
Buyback yield (%): 0
Retained earnings: -11734250.294695482
Receivables turnover: 14.00428206399451
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.98788064548577
FCF margin (%): -302.74165245757774
Revenue growth (%): 629.6198872369686
Rule of 40 score: 326.8782347793908
Financial ratios for NBX.OL — annual report dated 2024-12-31
Total revenue: 1434475.816416593
Gross profit: 448462.48896734335
Operating income: -2148850.3089143867
Net income: -2050983.5834068845
Capital expenditures: 641960.3706972639
Operating cash flow: -1732230.8031774051
Depreciation & amortization: 386160.9885260371
Net tangible assets: 1227289.1438658428
Owner earnings: -2306782.965578111
Return on net tangible assets (%): -187.9575792801333
Buffett classification: The Gruesome
Stock price: 0.03262786596119929
Shares outstanding: 271227657
Book value: 6457584.201235658
P/B ratio: 1.3704164532415652
Market cap (USD): 8849579.637566136
Debt to equity: 0.38205230850636446
Current ratio: 0.8539435545032997
Quick ratio: 0.8539435545032997
Interest coverage ratio: -9.397099021556633
COGS to revenue (%): 68.73683865318625
Free cash flow (dilution-adjusted): -2374191.173874669
Buyback yield (%): 0
Retained earnings: -11389515.887025597
Receivables turnover: 14.861717701988589
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.4877376647839
FCF margin (%): -165.5093203178246
Revenue growth (%): 59.07095936508402
Rule of 40 score: -106.43836095274058
Financial ratios for NBX.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1227289.1438658428
Buffett classification: The Gruesome
Stock price: 0.03262786596119929
Shares outstanding: 271227657
Book value: 6457584.201235658
P/B ratio: 1.3704164532415652
Market cap (USD): 8849579.637566136
Debt to equity: 0.38205230850636446
Current ratio: 0.8539435545032997
Quick ratio: 0.8539435545032997
Buyback yield (%): 0
Retained earnings: -11389515.887025597
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NERV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.41
Shares outstanding: 46588709
Market cap (USD): 298633624.69
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NERV — annual report dated 2022-12-31
Total revenue: 0
Operating income: -25231326
Net income: -32108676
Capital expenditures: 16326
Operating cash flow: -24645143
Depreciation & amortization: 8513
Net tangible assets: -34936185
Owner earnings: -32116489
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 46588709
Book value: -20024219
Market cap (USD): 74076047.31
Debt to equity: 0
Current ratio: 29.1518878087307
Quick ratio: 29.1518878087307
Interest coverage ratio: -3.406621026914672
Free cash flow (dilution-adjusted): -28770288
Buyback yield (%): 0
Retained earnings: -366810075
Capitalized R&D asset: 14649087
ROCI (R&D-adjusted, %): -22.623686590847836
Rule of 40 score: 0
Financial ratios for NERV — annual report dated 2023-12-31
Total revenue: 0
Operating income: -23119576
Net income: -30005353
Capital expenditures: 0
Operating cash flow: -14784732
Depreciation & amortization: 30982
Net tangible assets: -43343916
Owner earnings: -29974371
Buffett classification: The Gruesome
Stock price: 6.15
Shares outstanding: 46588709
Book value: -28457490
Market cap (USD): 286520560.35
Debt to equity: 0
Current ratio: 12.574010969289164
Quick ratio: 12.574010969289164
Interest coverage ratio: -2.7912258764905777
Free cash flow (dilution-adjusted): -16753113
Buyback yield (%): 0
Retained earnings: -396815428
Capitalized R&D asset: 22520141.29
ROCI (R&D-adjusted, %): -25.67372673854124
Rule of 40 score: 0
Financial ratios for NERV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.67
Shares outstanding: 46588709
Market cap (USD): 124391853.03
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NERV — annual report dated 2024-12-31
Total revenue: 0
Operating income: -21848386
Net income: 1438865
Capital expenditures: 0
Operating cash flow: -19550567
Depreciation & amortization: 22469
Net tangible assets: -40562499
Owner earnings: 1461334
Return on net tangible assets (%): -3.6026725079241295
Buffett classification: The Gruesome
Stock price: 2.22
P/E ratio: 71.88091584686542
Shares outstanding: 46588709
Book value: -25693100
Market cap (USD): 103426933.98
Debt to equity: 0
Current ratio: 7.849886352580544
Quick ratio: 7.849886352580544
Interest coverage ratio: -4.788978092478162
Free cash flow (dilution-adjusted): -20876092
Buyback yield (%): 0
Retained earnings: -395376563
Capitalized R&D asset: 25245313.22
ROCI (R&D-adjusted, %): -38.67883563214221
Rule of 40 score: 0
Financial ratios for NERV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.22
Shares outstanding: 46588709
Market cap (USD): 103426933.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NERV — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -3902884
Net income: -3752972
Capital expenditures: 0
Operating cash flow: -4071960
Depreciation & amortization: 1361
Net tangible assets: -44018242
Owner earnings: -3751611
Buffett classification: The Gruesome
Stock price: 1.7
Shares outstanding: 46588709
Book value: -29148843
Market cap (USD): 79200805.3
Debt to equity: 0
Current ratio: 9.205593351167773
Quick ratio: 9.205593351167773
Free cash flow (dilution-adjusted): -4369189
Buyback yield (%): 0
Retained earnings: -399129535
Capitalized R&D asset: 1362438
ROCI (R&D-adjusted, %): -9.29605031664426
Rule of 40 score: 0
Financial ratios for NERV — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -3374149
Net income: -3258588
Capital expenditures: 0
Operating cash flow: -2042138
Depreciation & amortization: 1360
Net tangible assets: -46978612
Owner earnings: -3257228
Buffett classification: The Gruesome
Stock price: 1.72
Shares outstanding: 46588709
Book value: -32109213
Market cap (USD): 80132579.48
Debt to equity: 0
Current ratio: 6.148041922480424
Quick ratio: 6.148041922480424
Free cash flow (dilution-adjusted): -2340356
Buyback yield (%): 0
Retained earnings: -402388123
Capitalized R&D asset: 2210874.46
ROCI (R&D-adjusted, %): -9.843092339838352
Rule of 40 score: 0
Financial ratios for NERV — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2844348
Net income: -2743954
Capital expenditures: 0
Operating cash flow: -2916098
Depreciation & amortization: 1361
Net tangible assets: -49449669
Owner earnings: -2742593
Buffett classification: The Gruesome
Stock price: 2.11
Shares outstanding: 46588709
Book value: -34580270
Market cap (USD): 98302175.99
Debt to equity: 0
Current ratio: 4.872234334036093
Quick ratio: 4.872234334036093
Free cash flow (dilution-adjusted): -3188995
Buyback yield (%): 0
Retained earnings: -405132077
Capitalized R&D asset: 2244669.0100000002
ROCI (R&D-adjusted, %): -11.25727087802488
Rule of 40 score: 0
Financial ratios for NERV — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -4981589
Net income: -283667663
Capital expenditures: 0
Operating cash flow: -4480740
Depreciation & amortization: 1360
Net tangible assets: -155617481
Owner earnings: -283666303
Buffett classification: The Gruesome
Stock price: 4.02
Shares outstanding: 46588709
Book value: -140748082
Market cap (USD): 187286610.17999998
Debt to equity: 0
Current ratio: 36.28049271918944
Quick ratio: 36.28049271918944
Free cash flow (dilution-adjusted): -4939768
Buyback yield (%): 0
Retained earnings: -688799740
Capitalized R&D asset: 3221973.12
ROCI (R&D-adjusted, %): -4.32116639233805
Rule of 40 score: 0
Financial ratios for NERV — annual report dated 2025-12-31
Total revenue: 0
Operating income: -15102970
Net income: -293423177
Capital expenditures: 0
Operating cash flow: -13510936
Depreciation & amortization: 5442
Net tangible assets: -155617481
Owner earnings: -293417735
Buffett classification: The Gruesome
Stock price: 4.02
Shares outstanding: 46588709
Book value: -140748082
Market cap (USD): 187286610.17999998
Debt to equity: 0
Current ratio: 36.28049271918944
Quick ratio: 36.28049271918944
Free cash flow (dilution-adjusted): -14838308
Buyback yield (%): 0
Retained earnings: -688799740
Capitalized R&D asset: 17924265.14
ROCI (R&D-adjusted, %): -17.133930269965898
Rule of 40 score: 0
Financial ratios for NIM.AX — annual report dated 2022-06-30
Operating income: -4051860
Net income: -4052448.275862069
Capital expenditures: 200979.3103448276
Depreciation & amortization: 16800
Net tangible assets: 1956410.3448275863
Owner earnings: -4236627.586206896
Return on net tangible assets (%): -216.5510726012983
Buffett classification: The Gruesome
Stock price: 0.2827586206896552
Shares outstanding: 356960124
Book value: 1956410.3448275863
P/B ratio: 51.59119740411274
Market cap (USD): 100933552.30344827
Debt to equity: 0
Current ratio: 6.070730841565033
Quick ratio: 6.070730841565033
Interest coverage ratio: -1828.5704948646126
Free cash flow (dilution-adjusted): -2698364.827586207
Buyback yield (%): 0.3122115487911801
Retained earnings: -5004916.551724138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -207.1068582678692
Rule of 40 score: 0
Financial ratios for NIM.AX — annual report dated 2023-06-30
Operating income: -4066866.8874172186
Net income: -4069448.344370861
Capital expenditures: 15781.456953642384
Depreciation & amortization: 46467.54966887417
Net tangible assets: 495607.28476821195
Owner earnings: -4038762.2516556294
Return on net tangible assets (%): -814.9118012953538
Buffett classification: The Gruesome
Stock price: 0.11258278145695365
Shares outstanding: 356960124
Book value: 487134.43708609266
P/B ratio: 82.49789086875133
Market cap (USD): 40187563.62913907
Debt to equity: 0.036631306478079
Current ratio: 2.59990695368191
Quick ratio: 2.59990695368191
Free cash flow (dilution-adjusted): -3554850.9933774834
Buyback yield (%): 0.39765852191971346
Retained earnings: -8875494.0397351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -824.9378035936896
Rule of 40 score: 0
Financial ratios for NIM.AX — annual report dated 2024-06-30
Operating income: -3029040
Net income: -1620990
Capital expenditures: 21116.666666666668
Depreciation & amortization: 44664.666666666664
Net tangible assets: 96816.66666666667
Owner earnings: -1597442
Return on net tangible assets (%): -1649.9659149595454
Buffett classification: The Gruesome
Stock price: 0.04
Shares outstanding: 356960124
Book value: 96816.66666666674
P/B ratio: 147.47879111723176
Market cap (USD): 14278404.96
Debt to equity: 0.09187812015837486
Current ratio: 0.9407853387356006
Quick ratio: 0.9407853387356006
Interest coverage ratio: -60.5808
Free cash flow (dilution-adjusted): -1534176
Buyback yield (%): 0.009268075370047028
Retained earnings: -10058657.333333334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3128.634876915129
Rule of 40 score: 0
Financial ratios for NMR.AX — annual report dated 2021-06-30
Operating income: -2756672.9323308268
Net income: -2756699.2481203005
Capital expenditures: 33611.27819548872
Depreciation & amortization: 5700
Net tangible assets: 1505593.2330827066
Owner earnings: -2784610.526315789
Return on net tangible assets (%): -184.95105219185203
Buffett classification: The Gruesome
Stock price: 0.18045112781954886
Shares outstanding: 1131712817
Book value: 1505593.2330827068
P/B ratio: 135.64012490767507
Market cap (USD): 204218854.19548872
Debt to equity: 0
Current ratio: 14.826927541737899
Quick ratio: 14.826927541737899
Interest coverage ratio: -2250.6906077348062
Free cash flow (dilution-adjusted): -2437750.3759398493
Buyback yield (%): 0.17187737950071597
Retained earnings: -3506975.939849624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -183.0954650803345
Rule of 40 score: 0
Financial ratios for NMR.AX — annual report dated 2022-06-30
Total revenue: 21149.655172413793
Gross profit: -80217.24137931035
Operating income: -3389734.4827586208
Net income: -3173417.2413793104
Capital expenditures: 113912.41379310345
Depreciation & amortization: 26140.689655172413
Net tangible assets: 343478.6206896552
Owner earnings: -3261188.965517241
Return on net tangible assets (%): -949.4590839363589
Buffett classification: The Gruesome
Stock price: 0.11034482758620691
Shares outstanding: 1131712817
Book value: 343478.6206896552
P/B ratio: 363.57038880098946
Market cap (USD): 124878655.66896553
Debt to equity: 0
Current ratio: 2.4768286961217387
Quick ratio: 2.4768286961217387
Interest coverage ratio: -1766.1210923463887
COGS to revenue (%): 479.2839208269475
SG&A to revenue (%): 5484.282779535005
Free cash flow (dilution-adjusted): -3250191.724137931
Buyback yield (%): 0.035944962705145356
Retained earnings: -6389781.379310345
Receivables turnover: 0.3410210504075528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -986.8836889913341
FCF margin (%): -15367.587308833601
Rule of 40 score: -15367.587308833601
Financial ratios for NMR.AX — annual report dated 2023-06-30
Operating income: -2738255.6291390727
Net income: -2468379.4701986755
Capital expenditures: 17403.973509933774
Depreciation & amortization: 29448.344370860927
Net tangible assets: 128942.38410596027
Owner earnings: -2456335.0993377483
Return on net tangible assets (%): -1904.9865692875817
Buffett classification: The Gruesome
Stock price: 0.019867549668874173
Shares outstanding: 1131712817
Book value: 128942.38410596029
P/B ratio: 174.37525107471376
Market cap (USD): 22484360.602649007
Debt to equity: 0
Current ratio: 1.130636090371376
Quick ratio: 1.130636090371376
Interest coverage ratio: -5703.125517241379
Free cash flow (dilution-adjusted): -2286092.715231788
Buyback yield (%): 0.21354651966739485
Retained earnings: -8604262.251655629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2123.6272681982296
Rule of 40 score: 0
Financial ratios for NMR.AX — annual report dated 2024-06-30
Operating income: -2466089.3333333335
Net income: -2493234.6666666665
Capital expenditures: 20874.666666666668
Depreciation & amortization: 25484.666666666668
Net tangible assets: -1156211.3333333333
Owner earnings: -2488624.6666666665
Buffett classification: The Gruesome
Stock price: 0.02
Shares outstanding: 1131712817
Book value: -1156211.3333333333
Market cap (USD): 22634256.34
Debt to equity: -0.6503811010328562
Current ratio: 0.03642461557632004
Quick ratio: 0.03642461557632004
Interest coverage ratio: -122.87440624480983
Free cash flow (dilution-adjusted): -1941370
Buyback yield (%): 0.34648955174523455
Retained earnings: -11154858.666666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOS.LS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.443181818181818
Shares outstanding: 512539396
Market cap (USD): 1252226933.4090908
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOS.LS — annual report dated 2022-12-31
Total revenue: 1618092553.1914895
Gross profit: 1129176595.744681
Operating income: 283569148.9361702
Net income: 238908510.6382979
Capital expenditures: 241036170.21276596
Depreciation & amortization: 407342553.1914894
Net tangible assets: -173900000
Owner earnings: 405214893.6170213
Return on net tangible assets (%): -233.01604003278973
Capex to operating income (%): 85.00084410346832
Buffett classification: The Gruesome
Stock price: 2.7234042553191493
P/E ratio: 5.842621379856974
Shares outstanding: 512539396
Book value: 1119513829.7872343
P/B ratio: 1.2468376316087053
Market cap (USD): 1395851972.0851066
Debt to equity: 1.5561789264526866
Current ratio: 0.5249068774061549
Quick ratio: 0.4592886370912952
Effective tax rate (%): 12.704049286872781
Interest coverage ratio: 7.202242637125101
COGS to revenue (%): 30.21557428729782
SG&A to revenue (%): 5.364143623270635
Free cash flow (dilution-adjusted): 182415957.44680852
Buyback yield (%): 0.5401261632969185
Retained earnings: 238908510.6382979
Inventory turnover: 6.836663046873837
Receivables turnover: 6.1762267123621415
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.929455796705685
FCF margin (%): 11.273518136339938
Rule of 40 score: 11.273518136339938
Financial ratios for NOS.LS — annual report dated 2023-12-31
Total revenue: 1774948888.8888888
Gross profit: 1265168888.8888888
Operating income: 366663333.3333333
Net income: 201482222.2222222
Capital expenditures: 255615555.55555555
Depreciation & amortization: 428345555.5555555
Net tangible assets: -244271111.1111111
Owner earnings: 374212222.2222221
Return on net tangible assets (%): -153.1954476810829
Capex to operating income (%): 69.71396709667059
Buffett classification: The Good
Stock price: 2.6666666666666665
P/E ratio: 6.7835847132914955
Shares outstanding: 512539396
Book value: 1105207777.7777781
P/B ratio: 1.236664951286183
Market cap (USD): 1366771722.6666665
Debt to equity: 1.7432297798201841
Current ratio: 0.7160280309737271
Quick ratio: 0.6559073282042969
Effective tax rate (%): 9.37287593458878
Interest coverage ratio: 4.529068650325272
COGS to revenue (%): 28.720827015989194
SG&A to revenue (%): 5.599723059318141
Free cash flow (dilution-adjusted): 309131111.1111111
Buyback yield (%): 0.4203741897985405
Retained earnings: 201105555.55555555
Inventory turnover: 9.515752359224308
Receivables turnover: 3.8557067309665007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.373294438341063
FCF margin (%): 17.416338749034402
Revenue growth (%): 9.693903812116277
Rule of 40 score: 27.110242561150677
Financial ratios for NOS.LS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3666666666666663
Shares outstanding: 512539396
Market cap (USD): 1725549299.8666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOS.LS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.875
Shares outstanding: 512539396
Market cap (USD): 1473550763.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOS.LS — annual report dated 2024-12-31
Total revenue: 1766940625
Gross profit: 1261766666.6666667
Operating income: 392452083.3333334
Net income: 284452083.3333334
Capital expenditures: 147609375
Depreciation & amortization: 416628125
Net tangible assets: -68782291.66666667
Owner earnings: 553470833.3333334
Return on net tangible assets (%): -804.670533537278
Capex to operating income (%): 37.61207578419871
Buffett classification: The Good
Stock price: 2.875
P/E ratio: 5.1803127832016225
Shares outstanding: 512539396
Book value: 1132268750
P/B ratio: 1.301414318376269
Market cap (USD): 1473550763.5
Debt to equity: 1.4243434549733298
Current ratio: 0.6747614654934172
Quick ratio: 0.6227249152304961
Effective tax rate (%): 13.456004462304932
Interest coverage ratio: 4.667938694849525
COGS to revenue (%): 28.59031883617104
SG&A to revenue (%): 5.210217990960129
Free cash flow (dilution-adjusted): 464145833.3333334
Buyback yield (%): 0.3012140318888082
Retained earnings: 283603125
Inventory turnover: 11.76076729071685
Receivables turnover: 5.518689384351605
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.674854635763657
FCF margin (%): 26.268332210276355
Revenue growth (%): -0.451182788361978
Rule of 40 score: 25.817149421914376
Financial ratios for NOS.LS — quarterly report dated 2025-03-31
Total revenue: 458009782.6086956
Gross profit: 328242391.3043478
Operating income: 74954347.82608695
Net income: 64136956.521739125
Capital expenditures: 52029347.82608695
Depreciation & amortization: 134439130.4347826
Net tangible assets: -143230434.7826087
Owner earnings: 146546739.13043475
Return on net tangible assets (%): -102.31536289955376
Capex to operating income (%): 69.41471620406624
Buffett classification: The Good
Stock price: 3.9673913043478257
P/E ratio: 7.926180368945531
Shares outstanding: 512539396
Book value: 1243743478.2608695
P/B ratio: 1.6349386978651406
Market cap (USD): 2033444342.8260868
Debt to equity: 1.4169941026564266
Current ratio: 0.6853997080376651
Quick ratio: 0.6359232100388639
Effective tax rate (%): 10.570523219673422
Interest coverage ratio: 4.264827756818604
COGS to revenue (%): 28.332886377498106
SG&A to revenue (%): 5.725622910085934
Free cash flow (dilution-adjusted): 129269565.2173913
Buyback yield (%): 0.0005879935578916916
Retained earnings: 64136956.521739125
Inventory turnover: 2.9159787015778416
Receivables turnover: 0.9384881967629352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.526302369356412
FCF margin (%): 28.22419304694935
Rule of 40 score: 28.22419304694935
Financial ratios for NOS.LS — quarterly report dated 2025-06-30
Total revenue: 539110588.2352941
Gross profit: 380863529.41176474
Operating income: 104427058.8235294
Net income: 68345882.35294119
Capital expenditures: 56209411.76470588
Depreciation & amortization: 143154117.6470588
Net tangible assets: -309001176.47058827
Owner earnings: 155290588.2352941
Return on net tangible assets (%): -50.255662457024705
Capex to operating income (%): 53.82648175478521
Buffett classification: The Good
Stock price: 4.188235294117647
P/E ratio: 16.203121900063685
Shares outstanding: 512539396
Book value: 1168165882.352941
P/B ratio: 1.8376119525329302
Market cap (USD): 2146635587.9529412
Debt to equity: 1.801444395991303
Current ratio: 0.5753691291740075
Quick ratio: 0.5384417182261187
Effective tax rate (%): -0.2969510721314872
Interest coverage ratio: 5.2011602015703735
COGS to revenue (%): 29.353357599881292
SG&A to revenue (%): 5.186101727463972
Free cash flow (dilution-adjusted): 93357647.05882353
Buyback yield (%): 0.13734214184574858
Retained earnings: 137421176.47058824
Inventory turnover: 3.9106291429235958
Receivables turnover: 1.106778670350744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4208123730871787
FCF margin (%): 17.316975235900525
Revenue growth (%): 17.707221266033002
Rule of 40 score: 35.02419650193353
Financial ratios for NOS.LS — quarterly report dated 2025-09-30
Total revenue: 537990588.2352941
Gross profit: 399367058.8235294
Operating income: 108043529.41176471
Net income: 76748235.29411764
Capital expenditures: 41675294.11764706
Depreciation & amortization: 156155294.11764705
Net tangible assets: -217790588.23529413
Owner earnings: 191228235.29411763
Return on net tangible assets (%): -87.80371862879613
Capex to operating income (%): 38.57268856778858
Buffett classification: The Good
Stock price: 4.2
P/E ratio: 10.288459645641971
Shares outstanding: 512539396
Book value: 1246327058.8235292
P/B ratio: 1.727207515844203
Market cap (USD): 2152665463.2000003
Debt to equity: 1.6359779040153755
Current ratio: 0.6068038907917291
Quick ratio: 0.5690479505117476
Effective tax rate (%): 13.9404345242026
Interest coverage ratio: 5.04820800351803
COGS to revenue (%): 25.7669060469022
SG&A to revenue (%): 4.860133131565827
Free cash flow (dilution-adjusted): 106994117.64705883
Buyback yield (%): 0
Retained earnings: 214169411.7647059
Inventory turnover: 3.3165390677775273
Receivables turnover: 0.968176438581225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5263697287517193
FCF margin (%): 19.887730377964193
Revenue growth (%): -0.2077495831914875
Rule of 40 score: 19.679980794772707
Financial ratios for NOS.LS — annual report dated 2025-12-31
Total revenue: 2144896470.5882354
Gross profit: 1520411764.7058823
Operating income: 493224705.88235295
Net income: 289295294.11764705
Capital expenditures: 211611764.70588237
Depreciation & amortization: 478148235.2941177
Net tangible assets: -125448235.29411764
Owner earnings: 555831764.7058823
Return on net tangible assets (%): -443.07659123519426
Capex to operating income (%): 42.90372363390031
Buffett classification: The Good
Stock price: 4.341176470588235
P/E ratio: 7.691186173460051
Shares outstanding: 512539396
Book value: 1322978823.5294118
P/B ratio: 1.681828859685629
Market cap (USD): 2225023966.1647058
Debt to equity: 1.4896436917757787
Current ratio: 0.6414812287152183
Quick ratio: 0.6007534275984099
Effective tax rate (%): 3.884098531101713
Interest coverage ratio: 6.218993369231454
COGS to revenue (%): 29.11491134633126
SG&A to revenue (%): 5.330848273494072
Free cash flow (dilution-adjusted): 472187058.8235294
Buyback yield (%): 0.1330851494463874
Retained earnings: 289264705.88235295
Inventory turnover: 14.726369815508392
Receivables turnover: 5.558759680468321
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.740867285026011
FCF margin (%): 22.01444523306212
Revenue growth (%): 21.39041008173296
Rule of 40 score: 43.40485531479508
Financial ratios for NOS.LS — quarterly report dated 2025-12-31
Total revenue: 572067058.8235295
Gross profit: 384907058.8235294
Operating income: 199627058.82352942
Net income: 75095294.11764707
Capital expenditures: 57412941.17647059
Depreciation & amortization: 33328235.29411765
Net tangible assets: -125448235.29411764
Owner earnings: 51010588.23529412
Return on net tangible assets (%): -40.66265907662875
Capex to operating income (%): 28.76009971535157
Buffett classification: The Good
Stock price: 4.341176470588235
P/E ratio: 7.825598376873376
Shares outstanding: 512539396
Book value: 1322978823.5294118
P/B ratio: 1.681828859685629
Market cap (USD): 2225023966.1647058
Debt to equity: 1.4896436917757787
Current ratio: 0.6414812287152183
Quick ratio: 0.6007534275984099
Effective tax rate (%): -13.18896237820923
Interest coverage ratio: 10.614475165770049
COGS to revenue (%): 32.7164441848652
SG&A to revenue (%): 5.567837583829127
Free cash flow (dilution-adjusted): 131920000
Buyback yield (%): 0
Retained earnings: 289264705.88235295
Inventory turnover: 4.413538632265224
Receivables turnover: 1.4825812549545705
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.370936009419567
FCF margin (%): 23.06023358018496
Revenue growth (%): 6.334027273602002
Rule of 40 score: 29.39426085378696
Financial ratios for NUVB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.5
Shares outstanding: 347201971
Market cap (USD): 2951216753.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUVB — annual report dated 2022-12-31
Total revenue: 0
Operating income: -119734000
Net income: -104199000
Capital expenditures: 357000
Operating cash flow: -96108000
Depreciation & amortization: 199000
Net tangible assets: 655076000
Owner earnings: -104357000
Return on net tangible assets (%): -15.93051798569937
Buffett classification: The Gruesome
Stock price: 1.92
Shares outstanding: 347201971
Book value: 655076000
P/B ratio: 1.0176342658256448
Market cap (USD): 666627784.3199999
Debt to equity: 0.0065030622401064915
Current ratio: 50.70420180837323
Quick ratio: 50.70420180837323
Free cash flow (dilution-adjusted): -112770000
Buyback yield (%): 0
Retained earnings: -267002000
Receivables turnover: 0
Capitalized R&D asset: 87815000
ROCI (R&D-adjusted, %): -8.193770267163904
Rule of 40 score: 0
Financial ratios for NUVB — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -99822000
Net income: -75802000
Capital expenditures: 55000
Operating cash flow: -67999000
Depreciation & amortization: 222000
Net tangible assets: 605122000
Owner earnings: -75635000
Return on net tangible assets (%): -12.499132406357726
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 347201971
Book value: 605122000
P/B ratio: 0.8663954974534062
Market cap (USD): 524274976.21
Debt to equity: 0.0066218051896972845
Current ratio: 44.112924001717474
Quick ratio: 44.112924001717474
Free cash flow (dilution-adjusted): -87581000
Buyback yield (%): 0
Retained earnings: -342804000
Receivables turnover: 0
Capitalized R&D asset: 130125050
ROCI (R&D-adjusted, %): -11.057997673330009
Rule of 40 score: 0
Financial ratios for NUVB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.29
Shares outstanding: 347201971
Market cap (USD): 795092513.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUVB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 347201971
Market cap (USD): 923557242.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUVB — annual report dated 2024-12-31
Total revenue: 7873000
Gross profit: 795000
Operating income: -167557000
Net income: -567939000
Capital expenditures: 162000
Operating cash flow: -130413000
Depreciation & amortization: 683000
Net tangible assets: 459166000
Owner earnings: -567418000
Return on net tangible assets (%): -123.57578740586193
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 347201971
Book value: 463788000
P/B ratio: 1.9913349264319042
Market cap (USD): 923557242.86
Debt to equity: 0.019222144600550252
Current ratio: 9.035351280818626
Quick ratio: 9.035351280818626
Interest coverage ratio: -491.36950146627566
COGS to revenue (%): 89.90219738346246
R&D to revenue (%): 1258.9737076082815
SG&A to revenue (%): 879.3725390575383
Free cash flow (dilution-adjusted): -162850000
Buyback yield (%): 0
Retained earnings: -910743000
Receivables turnover: 0.4832433095998036
Capitalized R&D asset: 175861580
ROCI (R&D-adjusted, %): -23.47342807860478
Rosenberg metric: 0.011151790598830114
FCF margin (%): -2068.461831576273
Rule of 40 score: -2068.461831576273
Financial ratios for NUVB — quarterly report dated 2025-03-31
Total revenue: 3084000
Gross profit: 990000
Operating income: -59004000
Net income: -53236000
Capital expenditures: 72000
Operating cash flow: -42627000
Depreciation & amortization: 310000
Net tangible assets: 415050000
Owner earnings: -52998000
Return on net tangible assets (%): -12.769063968196603
Buffett classification: The Gruesome
Stock price: 1.76
Shares outstanding: 347201971
Book value: 419460000
P/B ratio: 1.4568146401563915
Market cap (USD): 611075468.96
Debt to equity: 0.02720879225671101
Current ratio: 9.011729705146669
Quick ratio: 9.011464412946259
Interest coverage ratio: -1092.6666666666667
COGS to revenue (%): 67.89883268482491
R&D to revenue (%): 797.6977950713359
SG&A to revenue (%): 1147.632944228275
Free cash flow (dilution-adjusted): -50553000
Buyback yield (%): 0
Retained earnings: -963979000
Inventory turnover: 149.57142857142858
Receivables turnover: 0.5646283412669352
Capitalized R&D asset: 24601000
ROCI (R&D-adjusted, %): -9.175464516416193
FCF margin (%): -1639.2023346303504
Rule of 40 score: -1639.2023346303504
Financial ratios for NUVB — quarterly report dated 2025-06-30
Total revenue: 4833000
Gross profit: 2257000
Operating income: -63589000
Net income: -59007000
Capital expenditures: 181000
Operating cash flow: -48178000
Depreciation & amortization: 356000
Net tangible assets: 360762000
Owner earnings: -58832000
Return on net tangible assets (%): -16.307704248230134
Buffett classification: The Gruesome
Stock price: 1.95
Shares outstanding: 347201971
Book value: 372907000
P/B ratio: 1.8155836266146785
Market cap (USD): 677043843.4499999
Debt to equity: 0.15490189242894342
Current ratio: 9.39188618964374
Quick ratio: 9.383567424196757
Interest coverage ratio: -151.04275534441805
COGS to revenue (%): 53.300227601903586
R&D to revenue (%): 566.1493896130768
SG&A to revenue (%): 796.2756052141527
Free cash flow (dilution-adjusted): -60390000
Buyback yield (%): 0
Retained earnings: -1022986000
Inventory turnover: 4.666666666666667
Receivables turnover: 0.7238280664969298
Capitalized R&D asset: 43844670
ROCI (R&D-adjusted, %): -8.571606893122732
Rosenberg metric: 0.05150197146457461
FCF margin (%): -1249.534450651769
Revenue growth (%): 56.71206225680934
Rule of 40 score: -1192.8223883949597
Financial ratios for NUVB — quarterly report dated 2025-09-30
Total revenue: 13120000
Gross profit: 9771000
Operating income: -56434000
Net income: -55792000
Capital expenditures: 12000
Operating cash flow: -52889000
Depreciation & amortization: 534000
Net tangible assets: 314202000
Owner earnings: -55270000
Return on net tangible assets (%): -17.590594585648724
Buffett classification: The Gruesome
Stock price: 3.7
Shares outstanding: 347201971
Book value: 325882000
P/B ratio: 3.942062748786371
Market cap (USD): 1284647292.7
Debt to equity: 0.17659152699443356
Current ratio: 8.47675801030368
Quick ratio: 8.392948877896993
Interest coverage ratio: -8.636975818794001
COGS to revenue (%): 25.52591463414634
R&D to revenue (%): 219.8628048780488
SG&A to revenue (%): 284.7484756097561
Free cash flow (dilution-adjusted): -68922000
Buyback yield (%): 0
Retained earnings: -1078778000
Inventory turnover: 0.5865148861646234
Receivables turnover: 0.9472924187725632
Capitalized R&D asset: 55296870
ROCI (R&D-adjusted, %): -9.261397111589849
Rosenberg metric: 0.2746144287698268
FCF margin (%): -525.3201219512194
Revenue growth (%): 171.46699772398097
Rule of 40 score: -353.8531242272385
Financial ratios for NUVB — quarterly report dated 2025-12-31
Total revenue: 3059859.67
Gross profit: -4700572.72
Operating income: -271368572.72
Net income: -36592000
Capital expenditures: 89000
Operating cash flow: -29733000
Depreciation & amortization: 539000
Net tangible assets: 294502000
Owner earnings: -36142000
Return on net tangible assets (%): -12.27224263332677
Buffett classification: The Gruesome
Stock price: 8.96
Shares outstanding: 347201971
Book value: 305716000
P/B ratio: 10.175881079694882
Market cap (USD): 3110929660.1600003
Debt to equity: 0.18760876107236782
Current ratio: 6.9501647797059505
Quick ratio: 6.811397161654364
Interest coverage ratio: -40.666652588041366
COGS to revenue (%): 41.799302515072526
R&D to revenue (%): 1120.8683959026134
SG&A to revenue (%): 1317.9035756237802
Free cash flow (dilution-adjusted): -37810000
Buyback yield (%): 0
Retained earnings: -1115370000
Inventory turnover: 0.11208483042678118
Receivables turnover: 0.15804243944011157
Capitalized R&D asset: 62653280
ROCI (R&D-adjusted, %): -46.45676894924246
Rosenberg metric: -0.5016838632739374
FCF margin (%): -1235.6775825605102
Revenue growth (%): -76.67789885670732
Rule of 40 score: -1312.3554814172176
Financial ratios for NUVB — annual report dated 2025-12-31
Total revenue: 4597427.28
Gross profit: -4700572.72
Operating income: -271368572.72
Net income: -204627000
Capital expenditures: 354000
Operating cash flow: -173427000
Depreciation & amortization: 1739000
Net tangible assets: 294502000
Owner earnings: -203242000
Return on net tangible assets (%): -69.0120949942615
Buffett classification: The Gruesome
Stock price: 8.96
Shares outstanding: 347201971
Book value: 305716000
P/B ratio: 10.175881079694882
Market cap (USD): 3110929660.1600003
Debt to equity: 0.18760876107236782
Current ratio: 6.9501647797059505
Quick ratio: 6.811397161654364
Interest coverage ratio: -19.83398426545827
COGS to revenue (%): 202.24354696046439
R&D to revenue (%): 2503.7046371726406
SG&A to revenue (%): 3296.6698714155627
Free cash flow (dilution-adjusted): -217675000
Buyback yield (%): 0
Retained earnings: -1115370000
Inventory turnover: 0.8148277977390237
Receivables turnover: 0.237458151954961
Capitalized R&D asset: 205041100
ROCI (R&D-adjusted, %): -35.03660246710443
Rosenberg metric: -0.0554441905184677
FCF margin (%): -4734.71328077211
Revenue growth (%): -41.60514060713832
Rule of 40 score: -4776.318421379248
Financial ratios for NVM.DE — annual report dated 2022-03-31
Total revenue: 682920000
Gross profit: 351223333.3333333
Operating income: 82416666.66666667
Net income: 48857777.777777776
Capital expenditures: 20155555.555555556
Operating cash flow: 89484444.44444445
Depreciation & amortization: 34857777.777777776
Net tangible assets: 71728888.88888888
Owner earnings: 63560000
Return on net tangible assets (%): 88.6114381312349
Capex to operating income (%): 24.455679137175597
Buffett classification: The Great
Stock price: 9.822222222222221
P/E ratio: 8.650684038024197
Shares outstanding: 43030303
Book value: 75173333.33333337
P/B ratio: 5.6223820284971
Market cap (USD): 422653198.35555553
Debt to equity: 3.79777107721414
Current ratio: 1.5777879628512845
Quick ratio: 0.9578000241225425
Effective tax rate (%): 12.788392927931499
Interest coverage ratio: 3.901278072897491
COGS to revenue (%): 48.57035475116656
SG&A to revenue (%): 2.564966125851735
Free cash flow (dilution-adjusted): 68828888.88888888
Buyback yield (%): 0
Retained earnings: -536473333.3333333
Inventory turnover: 2.323022691194323
Receivables turnover: 16.315680496933982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.17806448276754
FCF margin (%): 10.078616659182464
Rule of 40 score: 10.078616659182464
Financial ratios for NVM.DE — annual report dated 2023-03-31
Total revenue: 761200000
Gross profit: 367526086.95652175
Operating income: 86935869.56521739
Net income: 54329347.82608695
Capital expenditures: 18316304.347826086
Operating cash flow: 106876086.95652173
Depreciation & amortization: 35290217.391304344
Net tangible assets: 113942391.30434783
Owner earnings: 71303260.86956522
Return on net tangible assets (%): 62.578343365735925
Capex to operating income (%): 21.068753829034396
Buffett classification: The Great
Stock price: 9.51086956521739
P/E ratio: 7.5328641988276015
Shares outstanding: 43030303
Book value: 116582608.69565213
P/B ratio: 3.5104343929477153
Market cap (USD): 409255599.18478256
Debt to equity: 2.399017304393228
Current ratio: 1.7508617518427185
Quick ratio: 1.2285016190489169
Effective tax rate (%): 29.522412893582818
Interest coverage ratio: 8.099341772151899
COGS to revenue (%): 51.71753981128195
SG&A to revenue (%): 2.0983744202517767
Free cash flow (dilution-adjusted): 87382608.69565217
Buyback yield (%): 0
Retained earnings: -481971739.13043475
Inventory turnover: 3.148871056086386
Receivables turnover: 14.7401389181225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.14268276629609
FCF margin (%): 11.479586008362082
Revenue growth (%): 11.46254319686054
Rule of 40 score: 22.94212920522262
Financial ratios for NVM.DE — annual report dated 2024-03-31
Total revenue: 683343010.7526882
Gross profit: 340656989.24731183
Operating income: 64287096.77419355
Net income: 37398924.73118279
Capital expenditures: 15792473.118279569
Operating cash flow: 68573118.2795699
Depreciation & amortization: 36193548.38709677
Net tangible assets: 93602150.5376344
Owner earnings: 57799999.99999999
Return on net tangible assets (%): 61.75071797817346
Capex to operating income (%): 24.565541003897167
Buffett classification: The Great
Stock price: 6.195652173913043
P/E ratio: 7.128568327628903
Shares outstanding: 43030303
Book value: 96652688.17204309
P/B ratio: 2.758338080070095
Market cap (USD): 266600790.32608694
Debt to equity: 3.4092026655689893
Current ratio: 1.8915086543448398
Quick ratio: 1.3465613441163562
Effective tax rate (%): 25.611686200701516
Interest coverage ratio: 3.1016289686656986
COGS to revenue (%): 50.14846367242636
SG&A to revenue (%): 2.0207424285100606
Free cash flow (dilution-adjusted): 51275268.8172043
Buyback yield (%): 0
Retained earnings: -493787096.7741935
Inventory turnover: 3.333068387420647
Receivables turnover: 15.378690349433743
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.012961291910326
FCF margin (%): 7.503591609245502
Revenue growth (%): -10.228190915306335
Rule of 40 score: -2.724599306060833
Financial ratios for NVM.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.822222222222222
Shares outstanding: 43030303
Market cap (USD): 250531986.35555553
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NVM.DE — quarterly report dated 2024-12-31
Total revenue: 129166666.66666667
Gross profit: 65416666.66666667
Operating income: 10104166.666666668
Net income: -2500000
Capital expenditures: 3437500
Operating cash flow: 3750000
Depreciation & amortization: 8333333.333333334
Net tangible assets: 98750000
Owner earnings: 2395833.333333334
Capex to operating income (%): 34.020618556701024
Buffett classification: The Good
Stock price: 5.114583333333334
Shares outstanding: 43030303
Book value: 101770833.33333331
P/B ratio: 2.162525974718527
Market cap (USD): 220082070.55208337
Debt to equity: 0
Current ratio: 2.2772424017790955
Quick ratio: 1.5389177168272794
Interest coverage ratio: 0.6830985915492958
COGS to revenue (%): 49.354838709677416
Free cash flow (dilution-adjusted): 104166.66666666667
Buyback yield (%): 0
Retained earnings: -469166666.6666667
Inventory turnover: 0.6144578313253012
Receivables turnover: 2.995169082125604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.249536178107607
FCF margin (%): 0.08064516129032258
Rule of 40 score: 0.08064516129032258
Financial ratios for NVM.DE — annual report dated 2025-03-31
Total revenue: 588547826.0869565
Gross profit: 295051086.95652175
Operating income: 46961956.521739125
Net income: 12100000
Capital expenditures: 18131521.739130434
Operating cash flow: 44943478.26086956
Depreciation & amortization: 34914130.43478261
Net tangible assets: 98866304.34782608
Owner earnings: 28882608.695652176
Return on net tangible assets (%): 29.21380432512067
Capex to operating income (%): 38.60895729660919
Buffett classification: The Good
Stock price: 4.58695652173913
P/E ratio: 16.31224206431908
Shares outstanding: 43030303
Book value: 102113043.47826082
P/B ratio: 1.9329374804138644
Market cap (USD): 197378128.97826084
Debt to equity: 3.1756897726305047
Current ratio: 2.201258031423789
Quick ratio: 1.5668025484585066
Effective tax rate (%): 56.30862211059221
Interest coverage ratio: 2.218257431842686
COGS to revenue (%): 49.86795059320656
SG&A to revenue (%): 2.045565356145561
Free cash flow (dilution-adjusted): 25897826.08695652
Buyback yield (%): 0
Retained earnings: -485341304.34782606
Inventory turnover: 2.872337935876433
Receivables turnover: 14.56683974065804
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.289305599878068
FCF margin (%): 4.400292540224281
Revenue growth (%): -13.87226958849213
Rule of 40 score: -9.47197704826785
Financial ratios for NVM.DE — quarterly report dated 2025-03-31
Total revenue: 149960869.56521738
Gross profit: 72551086.95652173
Operating income: 10875000
Net income: 2534782.608695652
Capital expenditures: 4544565.217391304
Operating cash flow: 32769565.217391305
Depreciation & amortization: 8827173.913043479
Net tangible assets: 98866304.34782608
Owner earnings: 6817391.304347827
Return on net tangible assets (%): 6.895566036698661
Capex to operating income (%): 41.789105447276356
Buffett classification: The Good
Stock price: 4.58695652173913
P/E ratio: 19.46696812392796
Shares outstanding: 43030303
Book value: 102113043.47826082
P/B ratio: 1.9329374804138644
Market cap (USD): 197378128.97826084
Debt to equity: 3.1756897726305047
Current ratio: 2.201258031423789
Quick ratio: 1.5668025484585066
Effective tax rate (%): 84.17773162228322
COGS to revenue (%): 51.61998782291033
Free cash flow (dilution-adjusted): 27854347.826086957
Buyback yield (%): 0
Retained earnings: -485341304.34782606
Inventory turnover: 0.7575793034487162
Receivables turnover: 3.71160313147346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3826988202009045
FCF margin (%): 18.574410715838916
Revenue growth (%): 16.098737727910223
Rule of 40 score: 34.67314844374914
Financial ratios for NVM.DE — quarterly report dated 2025-06-30
Total revenue: 151647058.82352942
Gross profit: 78470588.23529412
Operating income: 8823529.411764706
Net income: 18352941.17647059
Capital expenditures: 2117647.0588235296
Operating cash flow: 2705882.3529411764
Depreciation & amortization: 9294117.647058824
Net tangible assets: 105058823.52941176
Owner earnings: 25529411.764705885
Return on net tangible assets (%): 24.30011198208287
Capex to operating income (%): 24.000000000000004
Buffett classification: The Great
Stock price: 4.823529411764706
P/E ratio: 11.287853490875708
Shares outstanding: 43030303
Book value: 108352941.17647064
P/B ratio: 1.9155726634093366
Market cap (USD): 207557932.11764705
Debt to equity: 2.7187839305103134
Current ratio: 2.3705882352941177
Quick ratio: 1.6676470588235297
Effective tax rate (%): 25.238095238095237
Interest coverage ratio: 1.7857142857142856
COGS to revenue (%): 48.25446082234289
Free cash flow (dilution-adjusted): 588235.2941176471
Buyback yield (%): 0
Retained earnings: -506941176.47058827
Inventory turnover: 0.6506276150627615
Receivables turnover: 2.83920704845815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7938292274575458
FCF margin (%): 0.3878975950349108
Revenue growth (%): 1.124419499033866
Rule of 40 score: 1.512317094068777